Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-08 Purchase | 2023-09-12 4:07 pm | CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer | 11,650 | $1.7044 | $19,856 | 123,441 (Direct) | View |
| 2022-03-14 Sale | 2022-03-14 9:22 pm | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 2,266 | $5.5973 | $12,683 | 41,566 (Direct) | View |
| 2019-04-22 Purchase | 2019-04-22 9:34 pm | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 1,250 | $11.08 | $13,853 | 1,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-01 Option Award | 2024-01-02 9:24 pm | N/A 2034-01-01 | CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer | 366,475 | $0 | 489,916 (Direct) | View |
| 2023-02-10 Option Award | 2023-02-14 4:11 pm | N/A 2033-02-10 | CODEXIS INC. | CDXS | Ryali Sriram Chief Financial Officer | 484,428 | $0 | 484,428 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-11 9:06 pm | N/A 2032-03-10 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 167,000 | $0 | 186,832 (Direct) | View |
| 2021-07-29 Option Award | 2021-07-30 4:26 pm | N/A 2031-07-28 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-05-10 Option Award | 2021-05-11 8:32 pm | N/A 2031-05-09 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 87,000 | $0 | 87,000 (Direct) | View |
| 2021-03-12 Option Award | 2021-03-15 7:38 pm | N/A 2031-03-11 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 113,750 | $0 | 115,652 (Direct) | View |
| 2020-03-12 Option Award | 2020-03-13 5:35 pm | N/A 2030-03-11 | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 65,000 | $0 | 66,628 (Direct) | View |
| 2020-03-05 Option Award | 2020-03-13 5:35 pm | N/A N/A | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 229 | $7.31 | 66,628 (Direct) | View |
| 2019-09-05 Option Award | 2019-09-06 5:47 pm | N/A N/A | Eiger BioPharmaceuticals Inc. | EIGR | Ryali Sriram Chief Financial Officer | 149 | $9.367 | 1,399 (Direct) | View |